TCTR20230417001
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis combined with Adjustable-depth fractional microneedle bipolar radiofrequency for periorbital Rejuvenation
ASTRACO MEDICAL NETWORKS LTD.0 sites38 target enrollmentApril 17, 2023
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Healthy Patient
- Sponsor
- ASTRACO MEDICAL NETWORKS LTD.
- Enrollment
- 38
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 30\-65 years
- •2\. Both male and Female
- •3\.Tear trough with mild to moderate skin laxity at eye
Exclusion Criteria
- •1\. Subjects who are pregnant or lactation
- •2\. Subjects who had history of low platelet, coagulopathy, anemia, liver disease, cancer, immunocompromised host or epilepsy
- •3\. Subjects who has dermatits, wound or infection at treatment area
- •4\. Subjects who allergy to anesthesia cream
- •5\. Subjects who taken oral or injection contraceptive pills or coagulopathy drug
- •6\. Subjects who had history of botulinum toxin treatment within 12 months before arrived the project
- •7\. Subjects who had history of laser at treatment area within 6 months before arrived the project 8\. Subjects who had history of keloid or hypertrophic scar
- •9\. Subjects who had history of psychitic disease
- •10\. Subjects who had metalic equipment in the body
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for Facial ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Facial ContouringTCTR20230516008ASTRACO MEDICAL NETWORKS LTD.39
Recruiting
Phase 4
The study to evaluate the efficacy and safety of Bipolar Radiofrequency-Assisted Lipolysis for cheek and nasolabial fold ContouringHealthy patientBipolar Radiofrequency-Assisted Lipolysis, Cheek and nasolabial fold ContouringTCTR20230515001ASTRACO MEDICAL NETWORKS LTD.39
Completed
Phase 2
Randomized, Open Label Study of the Safety and Efficacy of BIO-11006 in the Treatment of Advanced Nonâ??Small Cell Lung Cancer.Health Condition 1: null- Advanced Nonâ??Small Cell Lung CancerCTRI/2018/01/011152Biomarck Pharmaceuticals60
Completed
Phase 2
To evaluate the clinical efficacy and safety of Bailing capsule in the treatment of patients with chronic kidney disease stage 2-4 (CKD stage 2-4)Stage 2 through 4 chronic kidney diseaseITMCTR2024000026Zhongda Hospital affiliated to Southeast University
Not yet recruiting
Phase 2
A clinical study to see the efficacy of bhunimbadi churna in prameha purvarupa with special reference to prediabetes.CTRI/2024/07/070227DR Deepika Suryawanshi